A Hybrid Structural Approach to Analyze Ligand Binding by the 5-HT4 Receptor
News Feb 15, 2013
Hybrid structural methods have been used in recent years to understand protein-protein or protein-ligand interactions where high-resolution crystallography or NMR data on the protein of interest has been limited. For G protein-coupled receptors (GPCRs), high-resolution structures of native structural forms other than rhodopsin have not yet been achieved; gaps in our knowledge have been filled by creative crystallography studies that have developed stable forms of receptors by multiple means. The neurotransmitter serotonin (5-hydroxytryptamine, 5-HT) is a key GPCR-based signaling molecule affecting many physiological manifestations in humans ranging from mood and anxiety to bowel function. However a high resolution structure of any of the serotonin receptors has not yet been solved. Here we used structural mass spectrometry along with theoretical computations, modeling and other biochemical methods to develop a structured model for human serotonin receptor subtype 4(b) (5-HT4R) in the presence and absence of its antagonist GR125487. Our data confirmed the overall structure predicted by the model and revealed a highly conserved motif in the ligand-binding pocket of serotonin receptors as an important participant in ligand binding. In addition, identification of waters in the transmembrane region provided clues as to likely paths mediating intra-molecular signaling. Overall, this study reveals the potential of hybrid structural methods, including mass spectrometry to probe physiological and functional GPCR-ligand interactions with purified native protein.
This paper was published online in Molecular and Cellular Proteomics and is free to access.
Biomarker for Glioblastoma Predicts Clinical Course and Sensitivity to TreatmentNews
Scientists validate a biomarker indicative of patients with Glioblastoma prognosis and likely response to specific therapies.READ MORE
A New Tactic in the Fight Against Drug-Resistant InfectionsNews
$1 million research grant could lead to life-saving antibiotics.READ MORE
Comments | 0 ADD COMMENT
Annual Conference on Antimicrobials and Drug Resistance
Sep 24 - Sep 25, 2018
1st Alpine Winter Conference on Medicinal and Synthetic Chemistry
Jan 28 - Feb 01, 2018